105 related articles for article (PubMed ID: 7547690)
1. A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin.
Rosen A; Lundman P; Carlsson M; Bhavani K; Srinivasa BR; Kjellström G; Nilsson K; Holmgren A
Int Immunol; 1995 Apr; 7(4):625-33. PubMed ID: 7547690
[TBL] [Abstract][Full Text] [Related]
2. Secretion of thioredoxin after in vitro activation of human B cells.
Ericson ML; Hörling J; Wendel-Hansen V; Holmgren A; Rosén A
Lymphokine Cytokine Res; 1992 Oct; 11(5):201-7. PubMed ID: 1334710
[TBL] [Abstract][Full Text] [Related]
3. Detection of adult T-cell leukemia-derived factor/human thioredoxin in human serum.
Kitaoka Y; Sorachi K; Nakamura H; Masutani H; Mitsui A; Kobayashi F; Mori T; Yodoi J
Immunol Lett; 1994 Jul; 41(2-3):155-61. PubMed ID: 8002031
[TBL] [Abstract][Full Text] [Related]
4. Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes.
Sahaf B; Rosén A
Antioxid Redox Signal; 2000; 2(4):717-26. PubMed ID: 11213477
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
[TBL] [Abstract][Full Text] [Related]
6. The thioredoxin system of Helicobacter pylori.
Windle HJ; Fox A; Ní Eidhin D; Kelleher D
J Biol Chem; 2000 Feb; 275(7):5081-9. PubMed ID: 10671551
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin acts as a B cell growth factor in channel catfish.
Khayat M; Stuge TB; Wilson M; Bengtén E; Miller NW; Clem LW
J Immunol; 2001 Mar; 166(5):2937-43. PubMed ID: 11207242
[TBL] [Abstract][Full Text] [Related]
9. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
10. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species.
Sahaf B; Söderberg A; Spyrou G; Barral AM; Pekkari K; Holmgren A; Rosén A
Exp Cell Res; 1997 Oct; 236(1):181-92. PubMed ID: 9344598
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
[TBL] [Abstract][Full Text] [Related]
13. A protein disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane tumor necrosis factor receptors: overexpression in chronic lymphocytic leukemia cells.
Söderberg A; Hossain A; Rosén A
Antioxid Redox Signal; 2013 Feb; 18(4):363-75. PubMed ID: 22775451
[TBL] [Abstract][Full Text] [Related]
14. Alternative forms of the human thioredoxin mRNA: identification and characterization.
Hariharan J; Hebbar P; Ranie J; Philomena ; Sinha AM; Datta S
Gene; 1996 Sep; 173(2):265-70. PubMed ID: 8964512
[TBL] [Abstract][Full Text] [Related]
15. Human growth factor for murine interleukin (IL)-9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA.
Van Damme J; Uyttenhove C; Houssiau F; Put W; Proost P; Van Snick J
Eur J Immunol; 1992 Nov; 22(11):2801-8. PubMed ID: 1425908
[TBL] [Abstract][Full Text] [Related]
16. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
[TBL] [Abstract][Full Text] [Related]
17. Truncated Escherichia coli thioredoxin induces proliferation of human blood mononuclear cells and production of reactive oxygen species as well as proinflammatory cytokines.
Liu SY; Liu IC; Lin TY
Cell Biochem Funct; 2016 Jun; 34(4):226-32. PubMed ID: 27029462
[TBL] [Abstract][Full Text] [Related]
18. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
20. Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma.
Pekkari K; Gurunath R; Arner ES; Holmgren A
J Biol Chem; 2000 Dec; 275(48):37474-80. PubMed ID: 10982790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
